Searched for
SUMMIT THERAPEUTICS SHARE PRICE
Why is Summit Therapeutics share price up today by 22%?Summit Therapeutics share price is up today by 22% after biopharma firm announced AstraZeneca would invest $2 billion in it. British drugma...
Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25% according to analystsThe coming earnings season will reflect the impact of the bad monsoon, higher oil prices, and, in pockets, higher inflation. Given that, in...
India joins SCO meeting in Islamabad to prepare for 2027 leaders' summitIndia is participating in a three-day meeting of the Shanghai Cooperation Organisation in Islamabad, which began on Monday. This meeting ai...
Why is Nvidia share price up today?Nvidia's share or stock (NVDA) price is rising by 2.9% today. The share price is $225.07 USD on the NASDAQ. The chip making company has rec...
Sun Pharma signs major deal with LIB Therapeutics of US, gains access to $3.7-bn global market for bad cholesterol inhibitor PCSK9Sun Pharma has signed an exclusive agreement with LIB Therapeutics for Lerodalcibep, a cholesterol-lowering medication. This deal covers al...
Top Nifty50 stocks analysts suggest buying in this volatile weekStock Reports Plus, powered by Refinitiv, is a comprehensive report that evaluates five key components of 4,000+ listed stocks – earnings, ...
Two Trades for Today: An auto ancillary for a 7.05% gain, a large-cap electronics maker’s stock for an almost 8% riseOur technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
Global Market: European shares rise as oil prices ease; Middle East tensions keep investors cautiousEuropean shares rose on Friday as easing oil prices supported risk appetite, while investors remained cautious over Middle East tensions. T...
Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
Global Market: Hong Kong stocks slide as investors await Trump-Xi summit detailsHong Kong stocks declined sharply on Friday, led by technology and AI shares, as investors awaited clarity from the Trump-Xi summit. The Ha...
Vitruvias Therapeutics thyroid tablet recall gets FDA’s highest-risk rating - here’s what to check and what patients need to knowA thyroid medicine recall has received the FDA’s highest-risk classification after testing found one lot of Thyroid Tablets, USP 30 mg coul...
Why US stocks are down: Dow, Nasdaq slide as Iran tensions push oil, yields higher amid Trump-Xi talksWall Street's main stock indexes fell as Middle East tensions weighed on financial markets. Oil prices have risen, which is causing a spike...
Vitruvias Therapeutics thyroid tablet recall: FDA issues serious Class I warning over ‘superpotent’ medicine — check lot number, expiration date and what patients should knowVitruvias Therapeutics thyroid tablet recall: The FDA has issued a serious Class I recall for one lot of Vitruvias Therapeutics thyroid tab...
Global Market: European shares edge lower as Middle East tensions, US-China talks in focusEuropean shares fell amid investor caution as tensions in the Middle East affecting energy markets persisted. Oil prices remained above $10...
Didn’t get NSE IPO shares? Should you buy after listing, wait for a dip or bet on BSE?NSE Shares: As the National Stock Exchange (NSE) emerges on the market, investors are presented with various investment avenues. Options in...
NSE shares jump 5% after muted debut, market value swells by Rs 19,290 crore. Why Macquarie, other brokerages are bullishNSE Share Price: National Stock Exchange shares made their market debut at Rs 1,800, which is slightly above the IPO price. The listing ref...
Celldex shares slip 15% as safety concerns cloud skin drug trial win(Rewrites throughout to add company comments, adds shares in paragraph 2, analyst comment in paragraph 5)- Celldex Therapeutics said on Tue...
Ichor Biologics seeks $80-100 million PE funding for minority stake saleIchor Biologics is seeking eighty to one hundred million dollars from private equity investors. The Hyderabad-based company operates in the...
Top Nifty50 stocks analysts suggest buying in this volatile weekStock Reports Plus, powered by Refinitiv, is a comprehensive report that evaluates five key components of 4,000+ listed stocks – earnings, ...